The Effect of Phenolic Compounds in Osteoarthritis; a Nutritional Intervention

Harokopio University

Status

Completed

Conditions

Symptomatic Knee Osteoarthritis

Treatments

Dietary Supplement: Ascorbic acid / phytochemical supplement

Dietary Supplement: Ascorbic acid

Study type

Interventional

Funder types

Other

Identifiers

NCT04783792

OA supplement_( )

Details and patient eligibility

About

The main objective of the study is to elucidate the beneficial effect of a dietary supplement with phenolic compounds in patients with OA versus ascorbic acid.

The analysis of the data is expected to clarify the role of the new supplement as one with a positive effect on OA-related biomarkers, on functional abilities and on the quality of life of patients with OA.

Enrollment

72 patients

Sex

All

Ages

35+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

symptomatic knee OA (patients with at least moderate symptoms)
patients should be able to walk without a medical or other support device (such as a walking stick, crutches, or a kneecap).

Exclusion criteria

Patients undergoing physical therapy or TENS, have rheumatoid arthritis, fibromyalgia, spinal disorders or any other disorders that according to the physician is a bias, stiffness> 30 minutes, have scheduled knee surgery or any other programmed surgery during the trial, show WOMAC pain scale <4 for pain overall, those with a diagnosis of kidney or liver disease, coagulation disorders, any form of cancer, HIV infection, type I diabetes, those with unregulated type II diabetes, those using illicit substances or having a history of substance or alcohol abuse over the past 2 years (or those who consume more than 2 typical alcoholic beverages / day in the present), those using corticosteroids within 2 months prior to randomization and during the trial, those who change their diet or supplementation 1 month or during the recruitment/trial, those using ascorbic acid supplement or any phytochemical-rich supplement, women on estrogen replacement therapy, during pregnancy or lactation and those judged by the researcher as unable to perceive and comply with the obligations laid down in the Protocol and for which consent and voluntary participation is sought.